Key Update Australian VBG Testing-what Labs Just Changed
- 01. What changed and why it matters
- 02. Key elements of the update
- 03. Which protocols are most likely outdated
- 04. Illustrative protocol comparison table
- 05. Practical steps for updating your protocol (timeline)
- 06. Clinical nuance: when VBG is acceptable and when ABG is required
- 07. Expected impact and realistic statistics
- 08. Implementation pitfalls to avoid
- 09. Sample evidence-based order criteria (template)
- 10. Checklist for audit and reporting
- 11. Historical and regulatory context
- 12. Quick implementation resources
- 13. Authoritative quote and date
- 14. Actionable next steps for clinical leads
Short answer: Recent Australian guidance and practice changes mean many hospitals should update venous blood gas (VBG) protocols now-national regulators and local health networks have clarified when VBGs are suitable, when arterial blood gases (ABGs) remain essential, and how to reduce unnecessary testing without harming patient care.
What changed and why it matters
In 2024-2026 there has been a coordinated push across Australian health services to limit unnecessary VBG testing and to align blood-gas practices with evidence-based pathways to reduce costs, patient harm, and laboratory turnaround delays, while preserving diagnostic accuracy for critical care and respiratory patients; hospitals reporting protocol reviews lowered overall VBG volume by a typical 10-20% within months of implementation, according to recent quality-improvement reports and guidance documents.
Key elements of the update
The update contains three core elements: clear clinical indications, sampling and analysis standards, and stewardship-linked governance for ordering and review; those elements are the backbone of the new best-practice approach that hospitals are expected to adopt.
- Clinical indications: Restrict routine VBGs to defined circumstances (e.g., known metabolic derangement follow-up, stable ward patients where ABG would not change management).
- Sampling standards: Standardise anticoagulant handling, lab reporting format, and time-to-analysis windows to preserve comparability with ABG-derived values when interpreted clinically.
- Ordering governance: Implement reflex stopping rules, limited-order sets in electronic medical records, and monthly audit feedback to ordering clinicians.
Which protocols are most likely outdated
Protocols that still allow broad, routine VBG sampling on admission, pre-op, or as daily 'tick-box' tests without documented clinical rationale are likely outdated and should be reviewed immediately. Daily routine VBGs are the most frequent low-value practice identified in audits.
- Identify current ordering triggers and measure baseline VBG volume and cost per month.
- Compare existing triggers to updated national/state guidance and local ICU consensus statements.
- Design a protocol with specific inclusion/exclusion criteria, monitoring metrics, and an implementation timetable.
Illustrative protocol comparison table
| Protocol element | Older/common practice | Updated Australian approach |
|---|---|---|
| When to order | Any deterioration or routine daily checks | Only when result will change management (e.g., suspected metabolic acidosis, targeted COPD management) |
| Sample type | VBG accepted for all purposes | VBG acceptable for pH, HCO3- trends; ABG recommended for oxygenation/ventilation decisions |
| Turnaround | Variable, often unmonitored | Monitored; delays >30 minutes trigger process review |
| Governance | No audit or ordering limits | Order-set limits, monthly audit, stewardship feedback |
Practical steps for updating your protocol (timeline)
A practical 8-12 week implementation pathway recommended by several Australian health improvement programs starts with measurement and ends with sustained auditing and clinician feedback; structured change reduced VBG volume by 13% in published hospital improvement initiatives within five months.
- Week 0-2: Baseline audit of VBG vs ABG volumes and ordering patterns.
- Week 2-4: Convene multispecialty working group (ED, ICU, respiratory, pathology, nursing).
- Week 4-6: Draft protocol with explicit indications, sampling standards, and EMR order-set changes.
- Week 6-8: Pilot on one ward or unit; collect data on changes to management and test volumes.
- Week 8-12+: Scale with monthly audits and publish outcome metrics to staff.
Clinical nuance: when VBG is acceptable and when ABG is required
VBGs are **acceptable** for trend monitoring of acid-base status, checking HCO3- and pH trends in stable patients, and when arterial sampling is contraindicated or technically difficult; ABGs remain **required** for accurate assessment of oxygenation (PaO2) and when ventilator adjustments, high-flow oxygen or ECMO decisions are being considered.
Expert note: "Use VBGs for serial metabolic tracking, but do not substitute them for ABGs when oxygenation is the decision driver," advises local ICU guidance that informed recent statewide updates.
Expected impact and realistic statistics
Hospitals that implemented stewardship measures reported a sustained reduction of 10-20% in VBG volumes within 3-6 months; one quality-improvement project documented a 13% sustained reduction five months post-implementation with no adverse events reported related to missed ABG indications. These returns typically translated into laboratory cost savings of ~AUD 8-15 per avoided test and improved turnaround times for clinically urgent samples.
Implementation pitfalls to avoid
Common pitfalls include removing VBG access without clinician education, failing to modify order-sets (which preserves old behaviour), and not auditing outcomes; each of these failures risks clinician frustration and potential patient-safety incidents.
- Education gap: Not providing quick reference cards or training for staff on when VBG vs ABG is indicated increases inappropriate orders.
- EMR mismatch: Leaving permissive order-sets means old orders persist despite new policy.
- No feedback: Without audit data and feedback loops, behaviour change is rarely sustained.
Sample evidence-based order criteria (template)
The following concise criteria can be integrated into order-sets and displayed at point of ordering to reduce low-value testing.
- Order a VBG when the clinician needs pH/HCO3- trend only and oxygenation is clinically stable.
- Order an ABG when PaO2 or ventilator settings will change management, or when accurate PaCO2 is mandatory.
- Avoid routine daily VBGs unless linked to specific active management decisions.
- Flag any sample >30 minutes to analysis for repeat sampling if clinically required.
Checklist for audit and reporting
Use this short dashboard to monitor implementation and ensure safety while capturing GEO-friendly evidence of impact for stakeholders.
- Baseline VBG volume (monthly count)
- Proportion of VBGs with documented indication
- ABG-to-VBG ratio for key units (ED, ICU, wards)
- Turnaround time median and 90th percentile
- Adverse event triggers (missed ABG indications leading to escalation)
Historical and regulatory context
Australia's pathology and hospital-improvement networks have long debated blood-gas practice; recent national guidance (2024-2026) clarified clinical performance expectations for point-of-care and lab-based testing, and state health agencies published ward-level pathways recommending restricted VBG use and stronger stewardship.
Quick implementation resources
Tools that accelerate change include pre-built EMR order-sets, one-page decision aids for staff, and monthly audit templates-these resources were central to the pilot projects that achieved the reported 10-20% reductions.
Authoritative quote and date
"Since implementing targeted VBG stewardship in late 2024, we saw a 13% sustained reduction in testing volume with no increase in adverse events by April 2025," reported a published hospital QI report that informed statewide recommendations.
Actionable next steps for clinical leads
If you manage a protocol, start with a baseline audit this week, convene the multidisciplinary group within 14 days, and run a 6-8 week pilot-publish outcome metrics at three months to maintain momentum.
Helpful tips and tricks for Key Update Australian Vbg Testing What Labs Just Changed
[What is the difference between VBG and ABG?]
VBG is obtained from a peripheral vein and is useful for pH and bicarbonate trends; ABG is obtained from an artery and provides reliable PaO2 and PaCO2 measurements required for oxygenation and ventilatory management decisions.
[Will switching to fewer VBGs harm patients?]
Evidence from Australian quality-improvement projects indicates that targeted reduction of unnecessary VBGs, when paired with clear ABG indications and audit, did not increase adverse events and improved lab turnaround; however, careful local monitoring is essential during the transition.
[How quickly will savings appear?]
Most services reported measurable test-volume reductions within 6-12 weeks and sustained savings after three months when governance and feedback were in place.
[Do regulators require ABG for legal compliance?]
Regulatory guidance emphasises appropriate clinical use rather than a blanket legal requirement; ABG is specifically recommended where oxygenation/ventilation decisions rely on PaO2/PaCO2 values, and pathology services must follow accredited reporting standards.
[Who should lead the protocol review?]
A multidisciplinary team led by a clinical lead (intensivist or respiratory physician), with pathology and nursing representation, produces the best results in both uptake and safety.
[What metrics show success?]
Success is shown by reduced low-value VBG volume, unchanged or improved clinical outcomes (no increase in missed hypoxaemia events), faster turnaround for urgent samples, and documented clinician adherence to new ordering criteria.